BRAVE Act of 2025
Summary
The BRAVE Act of 2025 is an early-stage authorization bill expanding VA mental health services with zero new funding. It has no direct revenue impact on private hospital operators HCA and UHS. Both stocks have declined sharply over the past 30 days driven by broader healthcare sector headwinds, not this procedural legislation.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.BRAVE Act appropriates $0 — no new money for VA mental health programs
- 2.No revenue catalyst for HCA or UHS — private hospitals not impacted by this authorization-only bill
- 3.Both HCA (-9.72%) and UHS (-5.94%) declines over 30 days are sector-wide, not legislative-driven
Market Implications
No market implications for HCA or UHS from the BRAVE Act. Both stocks are trading lower due to broader healthcare sector trends (inflation, labor costs, utilization normalization), not legislative catalysts. HCA at $427.24 has lost nearly 10% in 30 days, approaching its 52-week low of $330. UHS at $168.34 is down ~6% over the same period. The absence of any direct revenue or regulatory connection between this VA authorization bill and private hospital operations means investors should ignore this legislation for HCA and UHS positioning.
Full Analysis
The BRAVE Act of 2025 (HR6024) was introduced on November 12, 2025 by Rep. Jason Crow (D-CO) and referred to the Veterans' Affairs and Armed Services committees. The bill authorizes expanded VA mental health workforce waivers, Vet Center infrastructure improvements, and extends the Staff Sergeant Parker Gordon Fox Suicide Prevention Grant Program through fiscal year 2026. However, the bill explicitly appropriates zero new funding—all programs are authorized subject to future appropriations bills. The bill remains in early legislative stages, referred to subcommittee on December 3, 2025, with an identical companion bill (S609) also pending in the Senate.
The money trail stops at authorization: the BRAVE Act is a policy bill that sets program parameters without allocating a single dollar. Actual funding would require a separate VA appropriations bill, which has not been introduced. For private sector companies like HCA Healthcare (HCA) and Universal Health Services (UHS), there is no revenue mechanism—VA care is delivered through VA facilities and directly contracted community providers, not general private hospital admissions under this bill.
Structural winners and losers: There are no identifiable winners or losers in the private hospital sector from this bill. The primary beneficiaries would be VA employees and VA-contracted community providers, but no publicly traded companies are named in the bill text. The legislation focuses on VA licensure waivers for mental health counselors, Vet Center outreach assessments, and studies—none of which generate revenue for HCA or UHS. The bill does not expand VA purchasing of private sector care.
Real market data shows HCA at $427.24 on April 30, 2026, down 9.72% over 30 days from approximately $473, and down 1.21% over 7 days. UHS at $168.34 is down 5.94% over 30 days and 3.45% over 7 days. These declines align with broader healthcare sector pressure—not this procedural bill. HCA's 52-week range of $330-$556.52 and UHS's $152.33-$246.33 indicate stocks trading near the lower half of their ranges amid sector-wide weakness.
Timeline: As of April 30, 2026, the bill has been in subcommittee for nearly five months with no further action. With zero funding and bipartisan but low-profile sponsorship (8 cosponsors, none from leadership), passage probability is low in the current session. Even if enacted, the bill would not affect private hospital company financials.
Intelligence Surface
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
No confirming evidence found yet from contracts, insider trades, or congressional activity
What the bill does
Authorization bill with zero appropriated funds for VA mental health services; no direct revenue catalyst for private hospital operators
Who must act
HCA Healthcare (publicly traded for-profit hospital chain)
What happens
No change in reimbursement rates, patient volumes, or regulatory requirements for HCA's hospitals
Stock impact
HCA derives ~100% of revenue from inpatient and outpatient care; the bill does not expand private hospital eligibility for VA contracts or alter Medicare/Medicaid payments. Recent 30-day decline of -9.72% is driven by broader sector trends, not this legislation
What the bill does
Authorization bill with zero appropriated funds for VA mental health services; no direct revenue catalyst for private behavioral health operators
Who must act
Universal Health Services (publicly traded behavioral and acute care hospital chain)
What happens
No change in reimbursement rates, patient volumes, or regulatory requirements for UHS's behavioral health facilities
Stock impact
UHS operates ~335 behavioral health facilities and ~26 acute care hospitals; the bill does not expand private provider participation in VA programs. Recent 30-day decline of -5.94% is driven by broader sector trends, not this legislation
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
SPREZZATURA MANAGEMENT CONSULTING, LLC: $23.2M Department of Veterans Affairs Contract
Physician and Patient Safety Act
Nurse Staffing Standards for Hospital Patient Safety and Quality Care Act of 2025
Veterans’ Assuring Critical Care Expansions to Support Servicemembers (ACCESS) Act of 2025
CAPEX & D SQUARE, A JOINT VENTURE LLC: $23.2M Department of Veterans Affairs Contract
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Debt Collection Practices (Regulation F); Deceptive and Unfair Collection of Medical Debt".
To amend title XVIII of the Social Security Act to prevent hospitals or skilled nursing facilities that are owned by certain firms from participating in the Medicare program.
CHOICE for Veterans Act of 2025
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Realigning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries
This executive order directs the CDC and ACIP to review and potentially update the U.S. childhood vaccine schedule to align with recommendations from peer developed countries, which recommend fewer vaccines. It maintains insurance coverage for all currently available vaccines without cost sharing and emphasizes protecting religious liberty and parental authority.
Promoting Efficiency, Accountability, and Performance in Federal Contracting
This executive order mandates that federal agencies default to using fixed-price contracts for procurement, shifting away from cost-reimbursement models. It requires written justification and senior-level approval for any non-fixed-price contract over certain dollar thresholds (e.g., $10M for most agencies, $100M for the Department of War), and directs agencies to review and renegotiate their 10 largest non-fixed-price contracts within 90 days. The order also tasks OMB with implementation guidance and the Federal Acquisition Regulatory Council with proposing regulatory amendments within 120 days.